You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Harvard Business School
Dow
Baxter
Moodys

Last Updated: July 2, 2020

DrugPatentWatch Database Preview

LOSARTAN POTASSIUM Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Losartan Potassium, and when can generic versions of Losartan Potassium launch?

Losartan Potassium is a drug marketed by Alembic Pharms Ltd, Apotex Corp, Aurobindo Pharma, Cadista Pharms, Hetero Labs Ltd V, Hikma, Hisun Pharm Hangzhou, Ipca Labs Ltd, Lupin Ltd, Macleods Pharms Ltd, Micro Labs, Mylan, Prinston Inc, Sandoz, Strides Pharma, Teva, Torrent Pharms, Unichem Labs Ltd, Upsher Smith Labs, Watson Labs, Zydus Pharms Usa Inc, Apotex, and Teva Pharms. and is included in thirty-seven NDAs.

The generic ingredient in LOSARTAN POTASSIUM is hydrochlorothiazide; losartan potassium. There are thirty-two drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; losartan potassium profile page.

Drug patent expirations by year for LOSARTAN POTASSIUM
Drug Prices for LOSARTAN POTASSIUM

See drug prices for LOSARTAN POTASSIUM

Drug Sales Revenue Trends for LOSARTAN POTASSIUM

See drug sales revenues for LOSARTAN POTASSIUM

Recent Clinical Trials for LOSARTAN POTASSIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Steadman Philippon Research InstitutePhase 1/Phase 2
Office of Naval Research (ONR)Phase 1/Phase 2
United States Department of DefensePhase 1/Phase 2

See all LOSARTAN POTASSIUM clinical trials

Pharmacology for LOSARTAN POTASSIUM
Medical Subject Heading (MeSH) Categories for LOSARTAN POTASSIUM
Paragraph IV (Patent) Challenges for LOSARTAN POTASSIUM
Tradename Dosage Ingredient NDA Submissiondate
COZAAR TABLET;ORAL losartan potassium 020386

US Patents and Regulatory Information for LOSARTAN POTASSIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; losartan potassium TABLET;ORAL 091629-003 Jan 6, 2010 AB RX No Yes   Start Trial   Start Trial   Start Trial
Torrent Pharms LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; losartan potassium TABLET;ORAL 090528-003 Apr 6, 2010 AB RX No No   Start Trial   Start Trial   Start Trial
Sandoz LOSARTAN POTASSIUM losartan potassium TABLET;ORAL 077424-002 Oct 6, 2010 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Harvard Business School
Dow
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.